Download our eBook to

Expand cGMP single-use biomanufacturing capacity
with industry insights

Industry contributors:

GE Healthcare

Fujifilm Diosynth Biotechnologies

A success story driven by collaboration

The global pharmaceutical portfolio today reflects a greater prevalence of large molecule drugs, expansion in the number of personalized products, and a rise in orphan disease treatments. To meet therapy production demands, the industry needs to have the right capacity, in the right locations.

In this eBook, Fujifilm Diosynth Biotechnologies and GE Healthcare share how they were able to bring online the UK’s first cGMP single-use manufacturing facility in just 14 months. Learn about the 5 key factors they took into consideration to successfully expand their manufacturing capacity.

Download your eBook